Iron | | | | | | |
Sucrosomial ferric pyrophosphate (30 mg) plus L-ascorbic acid (70 mg) | Briguglio et al. [16] | RCT | N = 73, 67.3 ± 8.6. Intervention group: N = 37, Control group: N= 36 | Anemia | Older patients with no support lost −2.8 ± 5.1%, while the intervention group gained +0.7 ± 4.6% circulating hemoglobin from baseline (p = 0.019) | After 30 days of oral iron plus L-ascorbic acid therapy, no significant changes in the martial status were observed after treatment. |
Ferric carboxymaltose 1000 mg (body weight ≥ 50 kg) Ferric carboxymaltose 500 mg (body weight < 50 kg) For 1 day before and 3 days after surgery | Choi et al., 2022 [19] | RCT | 110 pt, Intervention group: N = 54, 71.4 ± 5.7 Control group: N = 55, 71.8 ± 6.2 | Hb and iron response, QoL | The FCM group demonstrated a significantly greater number of Hb responders (p < 0.001) and a higher Hb level (p = 0.008) at 2 weeks postoperatively. | In postoperative anemia, a single infusion of 5000 and 1000 mg ev of ferric carboxymaltose increases the Hb response and improved Hb and iron metabolism variables. However, intervention did not affect the transfusion rate or QOL. |
Ferrous sulphate (200 mg, containing 65 mg of elemental iron) 3 times daily for 3 weeks | Mundy et al., 2005 [22] | RCT | 31 pt, Intervention group: N = 18, 67.8 ± 10.5 Control group: N = 13, 67.0 ± 9.4 | Hemoglobin and absolute reticulocyte count | Administration of iron supplements after elective total hip or total knee arthroplasty does not appear to be worthwhile. | Administration of iron supplements after elective total hip or total knee arthroplasty does not appear to be worthwhile. |
Iron isomaltoside administered 30 min during surgical wound closure. | Yoo et al., 2021 [28] | RCT | 89 pt Intervention group N = 44 71 ± 6 Control group N = 45 70 ± 7 | Hb | The incidence of anemia at 30 days after surgery was significantly lower in the treatment group (p = 0.008) | The intra-operative administration of iron isomaltoside effectively prevents postoperative anemia |
Daily doses of rhEPO combined with iron supplement | Cao et al., 2020 [18] | RCT | 102 pt Group A: rhEPO + iron (3 days before surgery), Group B: rhEPO + iron (day of surgery), Group C: iron alone | Hb, blood loss, reticulocyte levels, complications | Patients in Group A had significantly lower total blood loss than Groups B and C (A vs. B: p = 0.010; A vs. C: p < 0.001). Group A patients had significantly smaller Hb decline than Group C on the third and fifth postoperative days (p = 0.049, p = 0.037), as well as than Group B on the fifth postoperative day (p = 0.048) | Daily dose of rhEPO combined with iron supplement administered 3 days before TKA procedures could significantly decrease perioperative blood loss and improve postoperative Hb levels, without significantly elevating risks of complications |
Glucosamine sulphate |
Oral glucosamine sulphate 1500 mg once-a-day for at least 12 months and up to 3 years. | Bruyere et al., 2008 [17] | RCT | 275 pt, Intervention group: N = 144, 62.9 ± 7.6 Control group: N = 131, 63.6 ± 6.6 | Number of knee arthroplasties | A significantly decreased (p = 0.026) cumulative incidence of total knee replacements in patients who had received glucosamine sulphate. | Treatment of knee OA with glucosamine sulphate for at least 12 months and up to 3 years may prevent surgery |
Essential Amino Acids |
20 g of EAA Twice daily between meals for 1 week before and 2 weeks after surgery. | Dreyer et al., 2013 [20] | RCT | 28 pt, Intervention group: N = 16, 68 ± 5 Control group: N = 12, 70 ± 5 | Muscle atrophy, muscle strength, and functional mobility | Patients receiving placebo exhibited greater quadriceps muscle atrophy, 2 weeks (p = 0.036) and 6 weeks after surgery (p = 0.001) | EAA treatment attenuated muscle atrophy and accelerated the return of functional mobility in older adults following surgery |
EAA 20 g of EAA twice-daily, for 7 days before and for 6 weeks after surgery | Muyskens et al., 2019 [23] | RCT | N = 41 | A biopsy during surgery, and two additional biopsies at either 1 or 2 weeks after surgery to study satellite cells and other key histological markers of inflammation, recovery, and fibrosis. | | |
L-arginine (Arg; 14,000 mg) and L-glutamine (Gln; 14,000 mg) (HMB/Arg/Gln), Beta-hydroxy beta-methylbutyrate (HMB; 2400 mg), (158 kcal of energy) for 5 days before the surgery and for 28 days after the surgery. Patients fasted on the day of surgery. | Nishizaki et al., 2015 [24] | RCT | N = 32 | Body weight, bilateral knee extension strength, rectus femoris cross-sectional area | The maximal quadriceps strength was 1.1 ± 0.62 Nm/Kg before surgery and 0.7 ± 0.9 Nm/Kg after surgery 14 days in the control group (p = 0.02), and 1.1 ± 0.3 Nm/Kg before surgery and 0.9 ± 0.4 Nm/Kg after surgery 14 days in the HMB/Arg/Gln group. | Consuming HMB/Arg/Gln supplementation may suppress the loss of muscle strength after TKA. Intervention with exercise and nutrition appears to enable patients to maintain their quadriceps strength. |
Isoleucine (603 mg, 6.7%), leucine (684 mg, 7.6%), lysine (756 mg, 8.4%), methionine (603 mg, 6.7%), phenylalanine (405 mg, 4.5%), threonine (405 mg, 4.5%), tryptophan (207 mg, 2.3%), valine (603 mg, 6.7%), arginine (630 mg, 7%), histidine (315 mg, 3.5%), and starch (1089 mg, 12.1%) From 1 week prior to surgery until 2 weeks after it. 3 times daily (after every meal) for a total of 9 g/day. | Ueyama et al., 2020 [25] | RCT | 60 pt Intervention group N = 30 75.9 Control group N = 30 75.8 | Rectus femoris muscle area | Improvement of VAS (p = 0.038), albumin level (p = 0.009), quadriceps area (p = 0.026), muscle diameter (p = 0.029) after 4 weeks from surgery | Perioperative essential amino acid supplementation prevents rectus femoris muscle atrophy and accelerates early functional recovery after surgery |
Threonine (405 mg, 4.5%), lysine (756 mg, 8.4%), isoleucine (603 mg, 6.7%), valine (603 mg, 6.7%), methionine (603 mg, 6.7%), tryptophan (207 mg, 2.3%), phenylalanine (405 mg, 4.5%), leucine (684 mg, 7.6%), histidine (315 mg, 3.5%), arginine (630 mg, 7%), and glycine (1089 mg, 12.1%); the remainder was starch (2700 mg, 30%). | Ueyama et al., 2023 [26] | RCT | 52 pt Intervention group N = 26 76.4 ± 8.3 Control group N = 26 75.2 ± 5.5 | Rectus femoris muscle area | Improvement in rectus muscle area (p = 0.02, p = 0.01), diameter (p = 0.009) after 1 year and 2 years | Perioperative EAA supplementation contributes to the recovery of rectus femoris muscle volume and quadriceps muscle strength in the 2 years after surgery |
Vitamin D3 |
50,000 international units vitamin D3 on the morning of surgery | Weintraub et al., 2023 [27] | RCT | 107 pt Intervention group N = 57 63.7 ± 9.5 Control group N = 50 64.5 ± 63.7 | KSS, TUG | There was no difference in improvement in KSS at 3 weeks (p = 0.6) or 6 weeks (p = 0.5) from baseline. There was no difference in change in TUGT at 3 weeks (p = 0.6) or 6 weeks (p = 0.6) from baseline. | Supplementation with vitamin D3 on the day of surgery failed to demonstrate statistically significant differences in functional KSS, TUGT times, or complications in the early postoperative period compared to placebo. |
Adenosine 5′-triphosphate supplementation |
ATP 20 mg ATP for 4 weeks | Long and Zhang, 2014 [21] | RCT | 232 pt, Intervention group: N = 119, 60.1 ± 4.5 Control group: N = 113, 58.9 ± 5.2 | Quadriceps strength, pain scores | Reduction in length of hospitalization (p = 0.0027) and analgesic consumption (p = 0.021) | Oral supplement of ATP could benefit patients recovering from knee arthroplasty |